The spread of the pandemic is shivering in the minds of people. Researchers from different parts of the world are trying to combat the infection in various ways. Russia has come up with an efficient medicine which can cure COVID-19 cases
According to the data from Johns Hopkins University, Russia has 405,843 active coronavirus cases, and it is the third highest in the world. The death toll remains low at 4,693 when compared to other countries. Russia’s Health Ministry has approved a temporary registration on the country’s first COVID-19 medicine, Aviifavir, an anti-influenza drug. It was developed by a joint venture of the Russian Direct Investment Fund and ChemRar group. Aviifavir, a favipiravir based drug, is a generic version of the Japanese flu drug Avigan. This drug limits the viral RNA replication, thereby preventing the further manifestation of the virus.
Russia conducted a trial with this drug using 40 coronavirus patients and found that 65% of those taking the favipiravir-based drug were tested negative for the virus within five days, which was two times higher than in the standard therapy group. The preliminary trial proved that it could shorten recovery times for COVID-19 patients. The body temperature of 68% of the patients who had taken the drug came back to normal temperature so early. RDIF CEO Kirill Dmitriev said that “the final stage of the efficacious drug Avifavir clinical trial with 330 patients is ongoing”. As the world’s first coronavirus approved treatment, 60,000 drug packs will be supplied to hospitals in Russia during June. Russia has also insisted on other countries not to show any dispute rather cooperate with them to fight against the virus.
Do you want to publish on Apple News, Google News, and more? Join our writing community, improve your writing skills, and be read by hundreds of thousands around the world!